ASML vs MBRX · P/E 57, $665.37B cap vs $8.2M cap
ASML Holding NV ADR (ASML) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the ASML and MBRX stock pages for the full models.
Not investment advice.